Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Tyra Biosciences, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +26 vs. Q2 2021
- Shares held
- 26.1M
- +26.1M vs. Q2 2021
- Total value
- $456.8M
- +$456.8M vs. Q2 2021
- New holders
- 26
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 168 | $2.22B |
| Q1 2026 | 164 | $2.52B |
| Q4 2025 | 133 | $1.49B |
| Q3 2025 | 116 | $778.4M |
| Q2 2025 | 121 | $541.5M |
| Q1 2025 | 117 | $499.5M |
| Q4 2024 | 113 | $675.8M |
| Q3 2024 | 95 | $1.11B |
| Q2 2024 | 79 | $748.6M |
| Q1 2024 | 77 | $768.4M |
| Q4 2023 | 62 | $495.2M |
| Q3 2023 | 59 | $502.1M |
| Q2 2023 | 59 | $616.7M |
| Q1 2023 | 51 | $573.0M |
| Q4 2022 | 46 | $267.8M |
| Q3 2022 | 49 | $313.8M |
| Q2 2022 | 48 | $255.6M |
| Q1 2022 | 46 | $386.6M |
| Q4 2021 | 45 | $494.2M |
| Q3 2021 | 26 | $456.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Tyra Biosciences, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 7,236,454 | $127.3M | 1.76% | +7,236,454 | New |
| Boxer Capital, LLC | 6,323,359 | $111.2M | 3.88% | +6,323,359 | New |
| FMR LLC | 1,908,659 | $33.6M | 0.00% | +1,908,659 | New |
| BVF Inc | 1,694,933 | $29.8M | 1.16% | +1,694,933 | New |
| Janus Henderson Group PLC | 1,374,648 | $22.8M | 0.01% | +1,374,648 | New |
| Frazier Management LLC | 1,250,000 | $22.0M | 1.76% | +1,250,000 | New |
| Cormorant Asset Management, LP | 1,069,932 | $18.2M | 0.74% | +1,069,932 | New |
| Logos Global Management LP | 1,003,394 | $17.6M | 1.27% | +1,003,394 | New |
| Perceptive Advisors LLC | 987,500 | $17.4M | 0.25% | +987,500 | New |
| Wellington Management Group LLP | 695,371 | $12.2M | 0.00% | +695,371 | New |
| Deerfield Management Company, L.P. (Series C) | 625,000 | $11.0M | 0.21% | +625,000 | New |
| Fairmount Funds Management LLC | 499,040 | $8.78M | 3.19% | +499,040 | New |
| Jennison Associates LLC | 468,750 | $8.24M | 0.01% | +468,750 | New |
| Woodline Partners LP | 366,035 | $6.44M | 0.11% | +366,035 | New |
| Goldman Sachs Group Inc | 207,283 | $3.65M | 0.00% | +207,283 | New |
| Ensign Peak Advisors, Inc | 125,000 | $2.20M | 0.00% | +125,000 | New |
| Millennium Management LLC | 93,501 | $1.65M | 0.00% | +93,501 | New |
| LMR Partners LLP | 54,000 | $950.0K | 0.01% | +54,000 | New |
| HRT Financial LP | 31,805 | $559.0K | 0.00% | +31,805 | New |
| Pinz Capital Management, LP | 27,700 | $487.0K | 0.22% | +27,700 | New |
| Samson Rock Capital LLP | 15,267 | $269.0K | 0.17% | +15,267 | New |
| Qube Research & Technologies Ltd | 11,456 | $202.0K | 0.00% | +11,456 | New |
| Maven Securities LTD | 10,140 | $178.0K | 0.02% | +10,140 | New |
| Bank of America Corp | 885 | $15.0K | 0.00% | +885 | New |
| Citigroup Inc | 440 | $8.00K | 0.00% | +440 | New |
| Red Tortoise LLC | 212 | $2.00K | 0.00% | +212 | New |